TJTao Jiang

Tao Jiang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tao Jiang has a total of 49 co-authors. Here are the top co-authors by number of shared publications:

  • Zijing Wang

    First Clinical Medical College, General Hospital of Ningxia Medical University, Yinchuan, China

    9 shared publications
  • Hengyi Lv

    First Clinical Medical College, General Hospital of Ningxia Medical University, 804 Shengli Road, Yinchuan 750004, China

    6 shared publications
  • Zhanyuan Sun

    First Clinical Medical College, General Hospital of Ningxia Medical University, Yinchuan, China

    6 shared publications
  • Hai Li

    Department of Anal-Colorectal Surgery, General Hospital of Ningxia Medical University, Yinchuan, China

    5 shared publications
  • Jinzhong Cao

    First Clinical Medical College, General Hospital of Ningxia Medical University, Yinchuan, China

    5 shared publications
  • Xi Chen

    Department of Obstetrics and Gynecology, Gansu Provincial Clinical Research Center for Gynecological Oncology, The First Clinical Medical College of Lanzhou University, Lanzhou, China

    5 shared publications

Latest Publications

  • Open Access

    Integrated multi-omics analyses reveal the role of PAXX in colorectal cancer progression and the tumor immune microenvironment

    by Jinzhong Cao, Zijing Wang, Xi Luo, Shaohua Hou, Xi Chen, Peng Yuan, Zhanyuan Sun, Shuai Zhang, Cunlin Li, Tao Jiang, et al.

    PAXX is a DNA double-strand break repair factor involved in classical non-homologous end joining. Although elevated PAXX expression has been reported in colon cancer, its functional role and downstream mechanisms in colorectal cancer (CRC) remain incompletely defined. This study investigated the role of PAXX in CRC progression and its association with the tumor immune microenvironment. Public transcriptomic, proteomic, genomic, and single-cell datasets were integrated with clinical sample validation and functional experiments. Stable PAXX knockdown models were used to assess CRC cell proliferation, migration, invasion, and xenograft growth. RNA sequencing, Western blotting, and EGF-mediated rescue experiments were performed to evaluate EMT-related alterations and MAPK/ERK signaling. PAXX was upregulated in CRC tissues and cell lines and was associated with poorer overall survival, although its standalone prognostic discrimination was limited. PAXX knockdown suppressed proliferation, migration, invasion, and xenograft growth and attenuated EMT-related molecular alterations. RNA-seq and enrichment analyses showed coordinated suppression of MAPK signaling and EMT-related transcriptional programs following PAXX depletion. Consistently, p-MEK1/2 and p-ERK1/2 levels were reduced without substantial changes in total MEK1/2 or ERK1/2. EGF-mediated pathway stimulation restored MEK/ERK phosphorylation and partially reversed the inhibitory effects of PAXX depletion on malignant phenotypes and EMT-related alterations. High PAXX expression was also associated with distinct immune and stromal characteristics, while single-cell and CellChat analyses identified heterogeneous PAXX expression and predicted HGF- and VEGF-related intercellular communication. PAXX is associated with CRC progression and unfavorable prognosis. Functional and rescue experiments support MAPK/ERK signaling as a partial mediator of PAXX-associated malignant phenotypes. Immune and intercellular communication findings remain computationally inferred and require further validation.

  • Open Access

    Integrative machine learning models reveal immune and metabolic signatures predictive of colorectal cancer prognosis

    by Zhanyuan Sun, Zijing Wang, Qingchen Lv, Shaohua Hou, Guo Li, Tao Jiang, Hai Li

    Background: The progression of colorectal cancer (CRC) is profoundly shaped by immune and metabolic dysregulation within the tumor microenvironment (TME). This study aimed to develop an immune–metabolism-related gene (IMRG)-based prognostic model and experimentally validate its key molecular drivers. Methods: Transcriptomic and clinical data from the TCGA and GEO cohorts were analyzed to identify differentially expressed IMRGs. Molecular subtypes were defined using non-negative matrix factorization (NMF) clustering, and a machine learning–based prognostic model integrating 101 algorithmic combinations was constructed and validated. Gene Set Enrichment Analysis (GSEA), immune infiltration profiling, and drug sensitivity analyses were performed to elucidate biological and immunological differences. IL20RB, identified as a hub IMRG, was further validated through qRT–PCR, Western blotting, and IHC. Its functional role was assessed using CCK-8, wound-healing, and Transwell assays. Results: NMF clustering revealed two distinct molecular subtypes of CRC with divergent survival outcomes and immune characteristics. The 4-gene IMRG-based model demonstrated robust prognostic performance (C-index = 0.657) and was externally validated in a GEO cohort (AUC up to 0.824 for 1-, 3-, and 5-year survival). GSEA showed that the high-risk group was enriched for complement/coagulation cascades and extracellular matrix remodeling, whereas the low-risk group was enriched for metabolic programs including butanoate metabolism and the TCA cycle. Immune profiling indicated increased CD8⁺ T-cell infiltration in the high-risk group and a distinct immune checkpoint landscape, with most checkpoints elevated in the low-risk group, while ADORA2A, TNFRSF25 and CD276 were relatively higher in the high-risk group. Experimental analyses confirmed that IL20RB was significantly upregulated in CRC tissues and cell lines, and its silencing markedly inhibited CRC cell proliferation, migration, and invasion, consistent with its predicted oncogenic role. Conclusion: This integrative transcriptomic and computational analysis combined with machine learning and experimental validation identified IMRGs—particularly IL20RB—as critical mediators of CRC progression. The proposed IMRG-based prognostic model offers a robust framework for patient risk stratification, immune landscape characterization, and therapeutic targeting in CRC.

  • Prognostic signature and immune microenvironment characterization in colorectal cancer based on interleukin-related genes

    by Jinzhong Cao, Shaohua Hou, Zijing Wang, Zhanyuan Sun, Xin Chang, Xi Chen, Hengyi Lv, Tao Jiang, Hai Li

  • Open Access

    Integrative network toxicology and experimental evidence reveal mechanisms underlying diethyl phthalate-induced initiation and progression of endometrial cancer

    by Xi Chen, Zijing Wang, Fengfeng Wang, Yuexiao Wu, Dan Hu, Yuemei Cheng, Yijuan Xing, Junhong Du, Tao Jiang, Yongxiu Yang, et al.

    Diethyl phthalate (DEP) is a ubiquitous environmental endocrine-disrupting chemical (EDC). Epidemiological studies have suggested a potential association between DEP exposure and an increased risk of endometrial cancer (EC); however, its underlying molecular mechanisms remain largely unclear. Four GEO datasets were integrated, and differential expression analysis combined with weighted gene co-expression network analysis (WGCNA) was performed to identify candidate genes potentially linking DEP exposure to EC. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were conducted to explore relevant signaling pathways. Machine learning models, coupled with Shapley Additive Explanations (SHAP), were employed to prioritize key genes. Molecular docking and molecular dynamics (MD) simulations were used to assess the binding affinity between DEP and the identified targets. A series of in vitro experiments in EC cell lines were subsequently conducted to validate the biological effects of DEP. Nineteen overlapping DEP–EC genes were identified, predominantly enriched in the MAPK, cAMP, and cGMP–PKG signaling pathways. Among them, FOS, NR4A1, ADRA2C, JUN, and SLC6A2 were prioritized as core genes through machine learning and SHAP analysis. Molecular simulations confirmed stable binding between DEP and these targets. In vitro assays demonstrated that DEP exposure induces oxidative stress, significantly enhances ERK1/2 and AKT phosphorylation, upregulates Cyclin D1/CDK4 expression, promotes G1/S phase transition, and facilitates EC cell proliferation. These findings suggest that DEP may promote endometrial carcinogenesis by triggering oxidative stress-mediated signaling crosstalk and accelerating cell cycle progression. This study establishes a multi-layered methodological framework-from computational screening and machine learning to experimental validation-offering novel mechanistic insights into the carcinogenic potential of environmental endocrine disruptors such as DEP.


  • Open Access

    Intratumor heterogeneity score reveals immune landscape and survival stratification in colorectal cancer

    by Zijing Wang, Liyuan Ma, Jinzhong Cao, Xi Chen, Xin Chang, Ruxue Ma, Hengyi Lv, Zixin Zhang, Hai Li, Tao Jiang

    Background: Intratumor heterogeneity (ITH), a critical driver of tumor evolution and immune evasion, remains inadequately characterized at the transcriptomic level in colorectal cancer (CRC), and its clinical implications are not yet fully understood. Methods: We integrated transcriptomic datasets from TCGA-COAD/READ and two independent GEO cohorts (GSE40967 and GSE87211) to develop an RNA-seq–based ITH score using the DEPTH2 algorithm and to con0struct an ITH-related gene (ITRG) prognostic model. A unified cutoff value of 0.64 was established to stratify patients into high- and low-ITH groups. Using 52 survival-associated ITRGs, we generated a nine-gene prognostic signature selected from 101 distinct combinations of feature selection techniques and modeling algorithms and validated its performance in two external datasets. The tumor microenvironment and potential responsiveness to immune checkpoint inhibitors were evaluated using ssGSEA, ESTIMATE, and TIDE algorithms. SHAP analysis, together with in vitro and in vivo experiments, was employed to identify and functionally validate key regulatory genes. Results: Patients in the high-ITH group had markedly poorer overall survival (OS) than those in the low-ITH group. The ITH score correlated strongly with aggressive clinical features, including T3/4 invasion depth, N1/2 nodal status, and AJCC stage III. The nine-gene prognostic signature demonstrated consistent predictive capability across the TCGA training cohort and both GEO validation cohorts. In TCGA, the model yielded time-dependent AUCs of 0.669, 0.664, and 0.645 for 1-, 3-, and 5-year OS, respectively, and retained its status as an independent prognostic indicator in multivariate Cox regression analysis; in GSE40967 and GSE87211, the corresponding AUCs ranged from 0.544–0.573 and 0.648–0.744. The high-risk subgroup was characterized by a stromal immune phenotype enriched with cancer-associated fibroblasts and macrophages, elevated expression of multiple immune checkpoints, increased TIDE scores, and higher tumor mutational burden. SHAP analysis identified IL20RB as the top risk-associated gene, whose knockdown significantly suppressed CRC cell proliferation, migration, invasion, and tumorigenicity in vitro and in vivo . Conclusion: This study introduces and validates a transcriptomic ITH score and a nine-gene ITRG-based prognostic model that delineate the immune landscape and enables effective survival stratification in CRC, complementing the limitations of current staging systems. Additionally, IL20RB is highlighted as a promising therapeutic target, supporting the development of personalized immuno-targeted combination therapies in CRC.


  • Open Access

    A pseudouridine-related prognostic model of colorectal cancer based on single-cell sequencing analysis and transcriptome analysis

    by Zijing Wang, Liyuan Ma, Jinzhong Cao, Shengtao Lin, Ruxue Ma, Jiang Wang, Hengyi Lv, Zixin Zhang, Tao Jiang

    Urinary pseudouridine levels have been proposed as diagnostic biomarkers for various malignancies; however, their association with colorectal cancer (CRC) remains unclear. This study investigates the molecular mechanisms underlying pseudouridine-related genes (PRGs) in CRC. The study incorporated a training cohort (TCGA-CRC), a validation cohort (GSE87211), a single-cell dataset (GSE200997), and PRGs retrieved from public databases. Quality control was performed on the single-cell dataset, followed by cell type annotation. Differentially expressed genes (DEGs) across distinct cell populations were identified. Weighted gene co-expression network analysis (WGCNA) was employed to screen module genes strongly correlated with PRG scores. DEGs between tumor and normal samples in the training cohort were also determined. Candidate genes were selected by intersecting DEGs from key cell types, tumor-normal comparisons, and WGCNA-derived module genes. A prognostic risk model was constructed using Cox regression analyses. Independent prognostic factors were identified through univariate and multivariate Cox analyses, integrating clinical parameters and risk scores, to establish a prognostic nomogram. Comparative analyses of mutation profiles, immune infiltration, and functional pathways were conducted between high- and low-risk groups, and molecular mechanisms of prognostic genes were explored. Additionally, pseudo-temporal trajectory analysis was applied to assess prognostic gene expression dynamics in key cell types. Seven cell types were annotated in the single-cell dataset, with T cells and epithelial cells representing predominant and functionally significant populations. A total of 116 candidate genes were identified by overlapping 4,762 DEGs from T cells, 4,525 DEGs from epithelial cells, 9,772 tumor-normal DEGs, and 2,990 module genes. A prognostic risk model incorporating three PRGs—BCL10, TAF1B, and WWTR1—was developed and validated across training and validation cohorts. Risk score, age, T stage, N stage, and tumor stage were recognized as independent prognostic factors for constructing the nomogram. Pseudo-temporal trajectory analysis revealed that TAF1B expression was relatively elevated at the terminal differentiation phase in epithelial cells. A pseudouridine-related prognostic model based on three PRGs was established and validated, offering a potential reference for CRC treatment and risk stratification.

  • Multi-omics analysis identifies a glycosyltransferase-related prognostic signature linked to the immune landscape in colorectal cancer

    by Zijing Wang, Guo Li, Jinzhong Cao, Zhanyuan Sun, Xi Chen, Ruxue Ma, Hengyi Lv, Hai Li, Tao Jiang

  • Open Access

    Single-cell and Multi-omics Analysis Confirmed the Signature and Potential Targets of Cuproptosis in Colorectal Cancer

    by Tao Jiang, Zijing Wang, Zhanyuan Sun, Hengyi Lv, Guo Li, Hai Li

    Background: Cuproptosis, a form of copper-mediated programmed cell death, has recently garnered significant attention. However, the mechanisms by which CRGs affect the progression of CRC remain unclear.


  • Open Access

    Machine learning-based model for CD4+ conventional T cell genes to predict survival and immune responses in colorectal cancer

    by Zijing Wang, Zhanyuan Sun, Hengyi Lv, Wenjun Wu, Hai Li, Tao Jiang

    Globally, CRC ranks as a principal cause of mortality, with projections indicating a substantial rise in both incidence and mortality by the year 2040. The immunological responses to cancer heavily rely on the function of CD4Tconv. Despite this critical role, prognostic studies on CRC-related CD4Tconv remain insufficient. In this investigation, transcriptomic and clinical data were sourced from TCGA and GEO. Initially, we pinpointed CD4TGs using single-cell datasets. Prognostic genes were then isolated through univariate Cox regression analysis. Building upon this, 101 machine learning algorithms were employed to devise a novel risk assessment framework, which underwent rigorous validation using Kaplan-Meier survival analysis, univariate and multivariate Cox regression, time-dependent ROC curves, nomograms, and calibration plots. Furthermore, GSEA facilitated the examination of these genes’ potential roles. The RS derived from this model was also analyzed for its implications in the TME, and its potential utility in immunotherapy and chemotherapy contexts. A novel prognostic model was developed, utilizing eight CD4TGs that are significantly linked to the outcomes of patients with CRC. This model’s RS showcased remarkable predictive reliability for the overall survival rates of CRC patients and strongly correlated with malignancy levels. RS serves as an autonomous prognostic indicator, capable of accurately forecasting patient prognoses. Based on the median value of RS, patients were categorized into subgroups of high and low risk. The subgroup with higher risk demonstrated increased immune infiltration and heightened activity of genes associated with immunity. This investigation’s establishment of a CD4TGs risk model introduces novel biomarkers for the clinical evaluation of CRC risks. These biomarkers may enhance therapeutic approaches and, in turn, elevate the clinical outcomes for patients with CRC by facilitating an integrated treatment strategy.